OCX GROUP INC – Trademark Portfolio
Entity Type: 03
OCX GROUP INC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include ONECHRONOS. The owner is based in New York, NY.
STE 1204
110 Greene St.
New York, NY 10012
Showing of trademarks Trademarks
Trademark Classifications
OCX GROUP INC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does OCX GROUP INC have?
OCX GROUP INC has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 1 cancelled.
What trademark classes does OCX GROUP INC file in?
OCX GROUP INC files trademarks across 4 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 35 (Advertising & Business). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are OCX GROUP INC's most well-known trademarks?
OCX GROUP INC's registered trademark portfolio includes well-known marks such as ONECHRONOS. These are among 2 currently registered trademarks in the portfolio.
What is OCX GROUP INC's trademark registration success rate?
OCX GROUP INC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.